Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of new research in Science Advances detailing the company’s CRISPR-based ...
Romera-Paredes and colleagues’ work is the latest step in a long line of research that attempts to create programs automatically by taking inspiration from biological evolution, a field called genetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results